Form 4 for BHC Bausch Health Companies Inc.
Accepted 2022-03-04 00:00:00 ET · period of report 2022-03-02 · accession 0001127602-22-008296 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-03-04 | 2022-03-02 | BHC | APPIO THOMAS | CEO, Pharma Business | A - Grant | $0.00 | +152.7K | 480.8K | +47% | $0 |
| D | 2022-03-04 | 2022-03-02 | BHC | APPIO THOMAS | CEO, Pharma Business | A - Grant | $0.00 | +565.3K | 565.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares, No Par Value | 2022-03-02 | A | A | 152,690 | $0.00 | 480,831 | D | — | — | (F1) Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc. |
| 2 | Derivative | Non-Qualified Stock Options (right to purchase) | 2022-03-02 | A | A | 565,330 | $0.00 | 565,330 | D | $24.17 · — to 2032-03-02 | 565,330 Common Shares, No Par Value | (F2) The options vest in equal installments on each of the first three anniversaries of the date of grant. |